We are live on ! Find out more
NGM

North Growth Management Portfolio holdings

AUM $780M
1-Year Est. Return 102.77%
This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
AUM
$602M
AUM Growth
+$34.5M
Cap. Flow
-$23M
Cap. Flow %
-3.82%
Top 10 Hldgs %
41.13%
Holding
57
New
7
Increased
8
Reduced
10
Closed
8

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$9.93M
2
MLKN icon
MillerKnoll
MLKN
+$9.14M
3
AEO icon
American Eagle Outfitters
AEO
+$7.87M
4
CERN
Cerner Corp
CERN
+$7.82M
5
ITRI icon
Itron
ITRI
+$7.6M

Sector Composition

Rank Sector Weight
1 Technology 46.24%
2 Consumer Discretionary 23.1%
3 Healthcare 14.84%
4 Industrials 11.46%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
51
Boston Scientific
BSX
$67.9B
-170,000
Closed -$7.37M
GILD icon
52
Gilead Sciences
GILD
$181B
-142,000
Closed -$9.93M
MLKN icon
53
MillerKnoll
MLKN
$1.58B
-243,000
Closed -$9.14M
TPIC
54
DELISTED
TPI Composites
TPIC
-97,000
Closed -$3.28M
URBN icon
55
Urban Outfitters
URBN
$6.95B
-70,000
Closed -$2.06M
CTXS
56
DELISTED
Citrix Systems Inc
CTXS
-64,000
Closed -$6.92M
CERN
57
DELISTED
Cerner Corp
CERN
-111,000
Closed -$7.82M

Similar funds

North Growth Management's Q4 2021 Portfolio in Review

As of Q4 2021, North Growth Management held 57 positions worth $602M, up 6.1% from $567M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

North Growth Management withdrew a net $23M in Q4 2021, closing 8 positions and reducing 10 holdings. Its most notable exit was Gilead Sciences, an estimated $9.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, North Growth Management opened a new position in Global Payments worth $9.82M.

  • North Growth Management's largest Q4 2021 buy was Global Payments: 73,000 shares worth $9.82M.
  • North Growth Management added most to Tapestry in Q4 2021, an estimated $7.11M increase.
  • North Growth Management's biggest Q4 2021 reduction was Itron, cutting an estimated $7.6M.
  • North Growth Management fully exited Gilead Sciences in Q4 2021, selling an estimated $9.93M.
  • North Growth Management's ten largest holdings make up 41% of its $602M portfolio in Q4 2021.
  • North Growth Management opened 7 new positions and closed 8 in Q4 2021.
  • North Growth Management's portfolio value rose 6.1% quarter-over-quarter to $602M.

Based on North Growth Management's 13F filing for Q4 2021, filed 7 Feb 2022.